Sling-Fiber Preservation POEM vs. Conventional POEM for Reducing Post-POEM GERD

NCT07178821 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2025-10-22

No results posted yet for this study

Summary

Peroral endoscopic myotomy (POEM) is an effective, minimally invasive treatment for achalasia, offering excellent rates of symptom relief. However, a significant drawback is the high incidence of gastroesophageal reflux disease (GERD) following the procedure. One proposed technical modification, the selective preservation of the sling fibers during gastric myotomy (SFP-POEM), may reduce this risk without compromising efficacy as compared to a conventional POEM procedure, which includes myotomy of the sling fibers. In this study, adults with achalasia will be randomly assigned to receive one of the two POEM technical approaches. Researchers will monitor whether preserving sling fibers reduces the rates of reflux esophagitis (classified as Los Angeles Grade B or higher) on follow-up endoscopy. Participants will be followed for up to 1 year after the procedure.

Conditions

  • Achalasia, Esophageal
  • GERD (Gastroesophageal Reflux Disease)

Interventions

PROCEDURE

Conventional POEM

Standard posterior POEM with full-thickness myotomy, including both circular and gastric sling muscle fibers.

PROCEDURE

Sling Fiber-Preserving POEM

Posterior POEM with selective preservation of gastric sling fibers by limiting myotomy to the right of the second penetrating vessel.

Sponsors & Collaborators

  • Hoag Memorial Hospital Presbyterian

    collaborator OTHER
  • University of Ottawa

    collaborator OTHER
  • Vancouver General Hospital

    collaborator OTHER
  • Cedars-Sinai Medical Center

    collaborator OTHER
  • University of California, Irvine

    lead OTHER

Principal Investigators

  • Jason Samarasena, MD, MBA · University of California, Irvine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-01
Primary Completion
2027-12-01
Completion
2028-01-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07178821 on ClinicalTrials.gov